JB Hunt Q1 2026 Earnings EPS Edges Past Estimates Despite Slight Stock Dip Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage Minerva Neurosciences Inc NERV Q1 2026 Earnings Wider Loss Highlights Ongoing PreRevenue Development Stage ADPT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Sentiment Hycroft Mining HYMC Q3 2025 Earnings Narrower Loss Surprises as Development Progress Continues PONY Q1 2026 Earnings Narrower Loss Per ADS Drives Positive Investor Sentiment Lightbridge Corporation Q1 2026 Earnings Continued Investment in Nuclear Fuel Technology Amidst No Revenue PRTA Q1 2026 Earnings EPS Surges 27169 Above Estimates Despite No Revenue Stock Edges Lower ATOS Q1 2026 Earnings Loss Narrows Significantly Beating Estimates by 82 GYRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Marriott Vacations Worldwide Q1 2026 Earnings EPS Falls Short Amid Operational Headwinds EXC Q1 2026 Earnings Slight EPS Beat Bolsters Utilitys Steady Outlook SN Q1 2026 Earnings EPS Surpasses Estimates Amid Lingering Revenue Disclosures